Table 1.
Characteristics of 20 children with familial hypercholesterolaemia (HeFH) and 12 paediatric cardiac transplant recipients
| Sex | Age (years) | Weight (kg) | Height (cm) | Pravastatin dose (mg kg−1) | |
|---|---|---|---|---|---|
| Patients with HeFH | |||||
| 1 | Female | 13.0 | 42.0 | 153.8 | 0.24 |
| 2 | Female | 7.9 | 29.4 | 125.9 | 0.34 |
| 3 | Female | 6.9 | 26.1 | 125.1 | 0.38 |
| 4 | Female | 9.7 | 28.4 | 139.7 | 0.35 |
| 5 | Female | 9.8 | 33.0 | 141.0 | 0.30 |
| 6 | Female | 13.4 | 45.3 | 160.5 | 0.22 |
| 7 | Female | 11.9 | 43.5 | 152.5 | 0.23 |
| 8 | Female | 6.0 | 19.2 | 114.1 | 0.52 |
| 9 | Female | 14.0 | 63.0 | 161.9 | 0.16 |
| 10 | Female | 15.6 | 57.8 | 168.4 | 0.17 |
| 11 | Female | 11.7 | 45.0 | 157.8 | 0.22 |
| 12 | female | 12.0 | 44.5 | 161.4 | 0.22 |
| 13 | Female | 12.0 | 50.3 | 152.7 | 0.20 |
| 14 | Female | 10.3 | 27.5 | 134.5 | 0.36 |
| 15 | Male | 6.3 | 20.5 | 119.2 | 0.49 |
| 16 | Male | 7.7 | 23.1 | 120.8 | 0.43 |
| 17 | Male | 10.3 | 48.8 | 151.8 | 0.20 |
| 18 | Male | 4.9 | 16.4 | 108.9 | 0.61 |
| 19 | Male | 10.7 | 56.6 | 145.2 | 0.18 |
| 20 | Male | 10.7 | 42.5 | 142.3 | 0.24 |
| Mean ± SD | 10.3 ± 2.9 | 38.1 ± 13.8 | 141.9 ± 17.7 | 0.30 ± 0.13 | |
| Transplant recipients | |||||
| 21 | Female | 8.0 | 20.0 | 127.0 | 0.50 |
| 22 | Female | 18.7 | 46.3 | 160.0 | 0.22 |
| 23 | Female | 8.0 | 24.1 | 127.5 | 0.41 |
| 24 | Male | 11.6 | 42.5 | 146.0 | 0.24 |
| 25 | Female | 6.1 | 23.0 | 115.0 | 0.43 |
| 26 | Male | 13.8 | 40.3 | 143.0 | 0.25 |
| 27 | Female | 16.1 | 55.6 | 150.0 | 0.18 |
| 28 | Female | 4.4 | 15.5 | 103.0 | 0.65 |
| 29 | Female | 11.4 | 61.0 | 154.0 | 0.16 |
| 30 | Female | 16.9 | 71.0 | 163.0 | 0.14 |
| 31 | Female | 13.9 | 42.5 | 154.0 | 0.24 |
| 32 | Fale | 8.8 | 25.0 | 130.5 | 0.40 |
| Mean ± SD | 11.5 ± 4.5 | 38.9 ± 17.7 | 139.0 ± 18.8 | 0.32 ± 0.16 | |